Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405093 · ClinicalTrials.gov registry record
Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1,250
- Enrollment target
NCT00405093 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,250 participants.
The verdict
NCT00405093 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1,250 participants
- Enrollment target
Study Summary
Primary Objective: The aim of this study is to assess the effects of Aprotinin (an antifibrinolytic drug used to reduce bleeding during cardiac surgery) on renal function in patients undergoing surgery with use of hypothermic bypass and circulatory arrest for repair of the thoracic aorta. Secondary Objective: To compare the effects of Aprotinin and Amicar on major vascular outcomes following thoracic aorta surgery with use of hypothermic bypass and circulatory arrest.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2006-07 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00405093
The ClinicalTrials.gov registry entry for NCT00405093 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00405093 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00405093 about?
NCT00405093 is a clinical study titled "Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.". Primary Objective: The aim of this study is to assess the effects of Aprotinin (an antifibrinolytic drug used to reduce bleeding during cardiac surgery) on renal function in patients undergoing surgery with use of hypothermic bypass and circulatory arrest for repair of the thoracic aorta. Secondary...
What is the current status of trial NCT00405093?
This trial is currently completed. The enrollment target is 1,250 participants. The study started on 2006-07. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00405093?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.